As the world recovers from the crippling COVID- 19 pandemic, with widespread vaccination programmes and a swift adoption of comprehensive test-and-trace regimes, together with continual, strong international coordination from the private and public sectors, the business tourism is poised to make a come back in 2021. According to a latest study by World Travel & Tourism Council, more than 100 million lobs could return to the global Travel & Tourism sector during 2021 and this does send in a lot of positivity for the exhibition &
convenon industry as it is a travel based industry.
UFI, The Global Association of the Exhibition Industry has released the latest edition of
its flagship Global Barometer research, which tracks the pulse of the industry. The 26th UFI Global Barometer suggests that the impact of COVID-19 in 2020 has been severe, but there are positive signs for 2021, whereby Industry revenues are expected to double in 2021 compared to 2020, when revenues represented just 28% of 2019 revenues. It also states that on a global average, around 54% of companies have had to reduce their workforce, with half of these by more than 25%. Further, the report says that 64% of the respondents are confident that COVID-19 has reinforced the value of face-to-face
events, and that the sector will recover quickly. You can read the full report inside.
The Government of India has given permission that now all kind of exhibitions can be held anywhere for which the department of commerce will issue new procedures. Earlier, only B2B exhibitions were given permission by the government. Read the full story inside. As the acve cases decline steadily in India, it has also become the fastest country to reach 1 million Covid-19 vaccination, reaching this landmark figure in just six days. Meanwhile, India has also started exporting corona virus vaccines with a shipment to the neighboring Himalayan kingdom of Bhutan, the Ministry of External Affairs (MEA) said, as the so-called “pharmacy of the world” looks to bolster its vaccine diplomacy. Many low and middle-income countries are relying on India, the world’s biggest vaccine maker, for supplies to start COVID19 immunisation programmers and bring an end to their outbreaks. This edition carries some insightful stories and exclusive interviews. Do keep reading and subscribe to our social media channels on Facebook, LinkedIn, Instagram, Twitter and YouTube for latest updates and special video interviews.